Sp. Tofovic et Ek. Jackson, TACHYPHYLAXIS TO ANGIOTENSIN-II AND [PHE(4)]-ANGIOTENSIN-II IN THE RAT MESENTERY IN-VIVO, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 13-20
The existence of tachyphylaxis to angiotensin II (Ang II) in vivo is n
ot unequivocally established, and the hydroxyl group of the Ty(4) resi
due of Ang II has been suggested as a determinant of tachyphylaxis. In
view of these observations, we conducted a series of experiments to a
ssess and compare the ability of Ang II and [Phe(4)]-Ang II to induce
tachyphylaxis in vivo. All experiments were performed in the autoperfu
sed rat mesenteric vascular bed. The tachyphylaxis to intramesenteric
(IMA) infusions of Ang II was minimal, and after 120 min of continuous
infusion (33 pmol/min), Ang II retained most of its vasoconstrictor a
ctivity (67.7 +/- 6.6% of the initial response). Also most of the agon
ist activity was retained even when Ang II was administered continuous
ly in a dose-increasing manner (1-33 pmol/min). Continuous IMA infusio
ns of single doses of [Phe(4)]-Ang II caused an initial full response
that rapidly declined, and after 120 min retained only 18.2 +/- 9.2% o
f the initial response. Single continuous IMA infusion of [Phe(4)]-Ang
II induced greater vasoconstrictor responses compared with vascular r
esponses to the same doses delivered after the infusion of smaller dos
es. This difference was significant (P <.001, unpaired Student's t tes
t) for all doses (10, 100, 330 and 1000 pmol/min) of [Phe(4)]Ang II. I
n conclusion, although the development of tachyphylaxis to Ang II in v
ivo is minimal, tachyphylaxis to [Phe(4)]-Ang II does occur (at least
in rat mesenteric vascular bed). Thus, omission of the hydroxyl group
in position 4 dramatically increases the tachyphylactic potential, whi
le preserving full agonist activity. These results suggest that the hy
droxyl group of Tyr(4) may protect the Ang II receptor from changes th
at induce tachyphylaxis.